Publications by authors named "Fabiola Gevert"

Claim this Profile
S
Standardization of Measurable Residual Disease in Acute Myeloid Leukemia by Flow Cytometry: A Multicenter Study.
Maura Rosane Valerio Ikoma-Colturato, Felipe Magalhães Furtado, Camila Marques Bertolucci, Alef Rafael Severino, Elizabeth Xisto Souto, Fabíola Gevert

EJHaem· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How I Investigate Measurable Residual Disease in B-Cell Precursor Acute Lymphoblastic Leukemia After Therapy With Bi-Specific Monoclonal Antibodies and 19CAR-T Cells.
Maura Rosane Valerio Ikoma-Colturato, Felipe Magalhães Furtado, Elen de Oliveira, Fabiola Gevert, Roberia Mendonça

Int J Lab Hematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicentric standardization of minimal/measurable residual disease in B-cell precursor acute lymphoblastic leukaemia using next-generation flow cytometry in a low/middle-level income country.
Maura R V Ikoma-Colturato, Camila M Bertolucci, Joana E Conti-Spilari, Elen Oliveira, Anderson J Simioni, Fabiola Gevert

Br J Haematol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of flow cytometry and cytology to differentiate breast implant-associated anaplastic large cell lymphoma from reactive seromas in Brazilian patients.
Ana Paula De Azambuja, Fabíola Gevert, Raisa Merhy Oliveira, Ana Paula Sebastião, Anne Karoline Groth

Cytometry B Clin Cytom· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis